Anúncio
Anúncio
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
37.38
USDPatrocinado
-0.04
-0.11%
02 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
37.38
-0.01
-0.01%
Relatórios de Lucros HRMY
Rácio de surpresa positiva
HRMY separação 15 de 21 últimas estimativas.
71%
Próximo Relatório
Data do Próximo Relatório
23 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$242.71M
/$0.88
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+1.36%
/+1.15%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+20.59%
/+3.53%
Harmony Biosciences Holdings, Inc. Common Stock earnings per share and revenue
On 04 de nov. de 2025, HRMY reported earnings of 0.87 USD per share (EPS) for Q3 25, beating the estimate of 0.85 USD, resulting in a 1.62% surprise. Revenue reached 239.46 milhão, compared to an expected 228.15 milhão, with a 4.95% difference. The market reacted with a +4.74% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 13 analistas forecast an EPS of 0.88 USD, with revenue projected to reach 242.71 milhão USD, implying an aumentar of 1.15% EPS, and aumentar of 1.36% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Harmony Biosciences Holdings, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Harmony Biosciences Holdings, Inc. Common Stock reported EPS of $0.87, beating estimates by 1.62%, and revenue of $239.46M, 4.95% above expectations.
How did the market react to Harmony Biosciences Holdings, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 4.74%, changed from $29.33 before the earnings release to $30.72 the day after.
When is Harmony Biosciences Holdings, Inc. Common Stock expected to report next?
The next earning report is scheduled for 23 de fev. de 2026.
What are the forecasts for Harmony Biosciences Holdings, Inc. Common Stock's next earnings report?
Based on 13
analistas, Harmony Biosciences Holdings, Inc. Common Stock is expected to report EPS of $0.88 and revenue of $242.71M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio